Jurgi Camblong, Director, Chief Executive Officer, on June 25, 2026, sold 51,442 shares in Sophia Genetics (SOPH) for $298,155. Following the Form 4 filing with the SEC, Camblong has control over a total of 3,601,493 ordinary shares of the company, with 3,601,493 shares held directly.
SEC Filing: